Last updated on June 2018

A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)


Brief description of study

The main purpose of this study is to compare maintenance treatment with avelumab plus best supportive care (BSC) with BSC alone, to determine if avelumab has an effect on survival in patients with locally advanced or metastatic urothelial cancer that did not worsen during or following completion of first-line chemotherapy.

Clinical Study Identifier: NCT02603432

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

National Hospital Organization Sagamihara National Hospital
Sagamihara, Japan
3.49miles
  Connect »

Pfizer CT.gov Call Center

Kanagawa Cancer Center
Yokohama, Japan
3.94miles
  Connect »